Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infectious diseases

M Y Stoeckle1, R G Douglas

  • 1Cornell University Medical College, New York, NY.

JAMA
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

New conjugate vaccines effectively immunize infants from 2 months old, unlike older vaccines. This advancement is crucial as multidrug-resistant Streptococcus pneumoniae strains become significant threats.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Work-related musculoskeletal disorders in endoscopic sinus and skull base surgeons: an international survey.

Rhinology·2026
Same author

Outcome measures for chronic rhinosinusitis with nasal polyps.

Rhinology·2024
Same author

Topical anaesthesia and decongestion in rhinology.

Rhinology·2023
Same author

The EUFOREA pocket guide for chronic rhinosinusitis.

Rhinology·2022
Same author

Fluorescence in situ hybridisation in Carnoy's fixed tonsil tissue.

Scientific reports·2022
Same author

The in vitro efficacy of neutral electrolysed water and povidone-iodine against CRS-associated biofilms.

Rhinology·2021

Area of Science:

  • Immunology
  • Vaccinology
  • Microbiology

Background:

  • The initial Haemophilus influenzae type b (Hib) vaccine, using polysaccharide alone, had limitations in inducing robust immunity in young infants.
  • The emergence of multidrug-resistant strains of Streptococcus pneumoniae (pneumococcus) poses a growing public health challenge in the United States.
  • Developing effective vaccination strategies for infants is critical for preventing invasive bacterial diseases.

Purpose of the Study:

  • To highlight the advancements in conjugate vaccine technology for pediatric immunization.
  • To underscore the importance of addressing emerging infectious disease threats, such as resistant pneumococcal strains.

Main Methods:

  • Comparative analysis of vaccine efficacy based on conjugate versus polysaccharide formulations.

Related Experiment Videos

  • Review of epidemiological data on the prevalence of drug-resistant Streptococcus pneumoniae.

    • Main Results:

    • Conjugate vaccines demonstrate superior ability to induce protective immunity in infants as young as 2 months.
    • Multidrug-resistant Streptococcus pneumoniae strains are increasingly identified as significant pathogens.

    Conclusions:

    • Modern conjugate vaccines offer a more effective approach to infant immunization against bacterial pathogens.
    • Continued surveillance and development of vaccines against resistant bacteria are essential for public health.